← Back to All Filings

OHI CFO Awarded Shares Equaling 7% of Outstanding Stock

High SignificanceJanuary 15, 2026 at 11:31:53 PM UTC

OMEGA HEALTHCARE INVESTORS INC

$OHI4CIK: 0000888491

Subscribe to track OHI

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

OHI CFO Awarded Shares Equaling 7% of Outstanding Stock

Company: OMEGA HEALTHCARE INVESTORS INC (OHI) Form: 4 | Filed: 2026-01-15 Significance: High

Insider: STEPHENSON ROBERT O Title: CHIEF FINANCIAL OFFICER | Relationship: Officer

Transaction: • Type: Grant (Profits Interest Units) • Shares: 20,799 • Price: $0.00 • Value: $0 • Owned After: 231,374 units

Key Insight: The CFO was granted derivative securities representing 7.05% of the company's total shares outstanding, a highly significant transaction indicating substantial potential shareholder dilution upon vesting.

Market Context: This is an equity award, not an open-market purchase. The units vest after a three-year cliff, aligning the CFO's interests with long-term performance.

View Full Filing

This is PUBLIC SEC data for educational purposes. Not investment advice.

Comprehensive Analysis

SEC Filing Analysis: OMEGA HEALTHCARE INVESTORS INC (OHI)

Executive Summary

  • Trading Significance: High
  • Key Takeaway: The Chief Financial Officer, Robert O. Stephenson, was awarded 20,799 Profits Interest Units, which, based on the provided market data, represents a substantial 7.05% of the company's total shares outstanding.
  • Market Impact: While the transaction is a $0 value grant, its size relative to the shares outstanding is exceptionally large, signaling significant potential dilution for existing shareholders upon vesting.

Company Information

FieldValue
CompanyOMEGA HEALTHCARE INVESTORS INC
Ticker SymbolOHI
CIK0000888491
IndustryREAL ESTATE INVESTMENT TRUSTS [6798]

Insider Information

FieldValue
NameSTEPHENSON ROBERT O
CIK0001157251
Title/PositionCHIEF FINANCIAL OFFICER
RelationshipOfficer

Transaction Details

FieldValue
Form Type4
Transaction Date2026-01-13
Transaction CodeA (Award)
Security TypeProfits Interest Units
Shares Involved20,799
Price Per Share$0.00
Total Value$0
Shares Owned After231,374
Ownership TypeDirect

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$0
% of Market Cap0.00%
Shares Transacted20,799
% of Shares Outstanding7.05%
Post-Transaction Ownership231,374 units (78.43% of outstanding)
Materiality AssessmentHighly Significant

Impact Evaluation

  • Market Cap Context: For a large-cap company with a $12.99 billion market capitalization, a $0 value transaction is typically immaterial. However, the materiality of this filing is not based on dollar value but on the number of shares granted.
  • Ownership Concentration: Post-transaction, the CFO holds derivative securities representing an exceptionally high 78.43% of the company's stated shares outstanding. This level of insider ownership concentration is extraordinary.
  • Dilution Impact: The grant of 20,799 units represents 7.05% of the 295,000 shares outstanding. This is a massive potential dilution event, far exceeding the 0.5% threshold for high significance. Upon vesting and conversion, this could significantly impact earnings per share and the value of existing shares.
  • Transaction Significance: The transaction is rated Highly Significant due to the sheer volume of shares granted relative to the total shares outstanding. The percentage of shares (7.05%) is the primary driver of this assessment.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: This is a scheduled equity award as part of executive compensation, not an open-market transaction reflecting immediate sentiment. The long vesting period (cliff on 12/31/2028) defers any market impact. However, the scale of potential dilution could be viewed negatively by the market if not previously anticipated.

Volume & Sentiment

  • Expected Volume Impact: None. As this is not an open-market trade, it does not directly impact trading volume.
  • Sentiment Indicator: Neutral. While grants align executive and shareholder interests, the magnitude of this award relative to shares outstanding introduces a significant dilution risk factor that could temper bullish sentiment.

Investment Insights

Positive Market Indicators

  • The grant is designed to retain a key executive and align their compensation with long-term company performance, as indicated by the three-year vesting cliff.

Risk Factors

  • Massive Potential Dilution: The grant represents over 7% of the company's shares outstanding, posing a substantial dilution risk to current shareholders.
  • High Insider Concentration: The CFO's post-transaction holding of over 78% of the company (based on provided data) represents an extreme concentration of control and ownership, which can be a corporate governance concern.

Key Takeaways

  1. Dilution is the Story: The primary takeaway is the significant potential for shareholder dilution from this single grant.
  2. Long-Term Incentive: The award is a long-term incentive with a vesting date at the end of 2028, meaning the impact is not immediate.
  3. Unusual Scale: The size of the grant relative to the company's shares outstanding is exceptionally large and warrants close monitoring by investors.

Additional Context

Transaction Notes

  • Security Type: The securities are "Profits Interest Units" which are contingent rights to receive one OP Unit, which is then redeemable for one share of OHI common stock. This is a common structure in REITs.
  • Vesting Schedule: The units are subject to a three-year cliff vesting on December 31, 2028, contingent on continued employment.
Topics:#SECFiling#InsiderTrading#OHI#OmegaHealthcare#Form4#StockGrant#HighSignificance#CFO#REIT#Investing

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is AI-generated from public SEC filings and may contain errors. It is for informational and educational purposes only and is not investment, legal, or tax advice.

The Filing Fool is not a registered investment adviser, broker-dealer, or financial planner. Nothing here is a recommendation or solicitation to buy, sell, or hold any security.

Always do your own due diligence and consult a licensed professional.